Following the outcome of the UK’s referendum on membership of the European Union, the BIA has worked closely with members and stakeholders to identify the threats and opportunities for biotech post-Brexit and to represent the sector.
The BIA Brexit Briefing webinars provide a monthly update on Government policy, progress of working groups, and how these potentially affect companies in life sciences. Visit their dedicated microsite www.biabrexit.org to view all the information and guidance for the sector.
Chief Executive Officer
Steve Bates has been the CEO of the UK Bioindustry Association since 2012. He currently chairs the International Council of Biotech Associations and has been a Board member of EuropaBio since 2015. Steve is the visible face of the vibrant UK life sciences industry to government and media. He sits on the UK’s Life Sciences Council and Life Sciences Industrial Strategy Implementation Board.
Strategic Policy Advisor
Tim joined the BIA in August 2020 to lead its strategic policy work around Brexit and Covid-19. He has over eight years’ experience working in health policy and public affairs. Immediately prior to joining the BIA he worked as a Policy Manager at Prostate Cancer UK where he led on work around access to treatments and supporting clinicians with best practice guidance. He previously worked at the Association of the British Pharmaceutical Industry as a Public Affairs Manager.